The following online resources may provide you with additional education and support on caring for your foot sore and preventing the occurrence of others.

Click on one of the following to learn more:

The Wound Institute
The Wound Institute provides online wound care education programs for patients. These easy-to-follow education modules address the needs of the patient who has or is at risk of developing sores.

Diabetic Wound Care
Hosted by the American Podiatric Medical Association, this informative article provides the facts about diabetic foot sores.

Diabetes Foot Care
Provided by the National Institutes of Health, this interactive program provides people living with diabetes with an interactive tutorial on diabetes foot care.

Living With Diabetes Foot Complications
The American Diabetes Association provides this article about the potential foot complication risks for people with diabetes.

Taking Care of Your Feet for a Lifetime
The Centers for Disease Control National Diabetes Education Program provides this booklet to help people with diabetes care for their feet and offers tips to prevent serious foot problems.

Have a question?

Get answers to frequently asked questions about REGRANEX Gel.

See FAQs
Comprehensive information is at hand

Educational materials about diabetes, foot care, and REGRANEX Gel are available to help you better understand your treatment.

Learn about tools and resources
Important Safety Information

People who use 3 or more tubes of REGRANEX (becaplermin) Gel may have an increased risk of death from cancer.

REGRANEX Gel is a man-made protein medicine that is used with other ulcer care practices (such as good wound care) to treat diabetic sores (ulcers) of your legs or feet that are deeper than just your skin, in people who have good blood supply to the legs.

Do not use REGRANEX Gel if you have a skin tumor at the area where you apply the product.

Before you use REGRANEX Gel, tell your healthcare provider if you:

If you decide to use REGRANEX Gel, use the product exactly as your healthcare provider tells you to use it. This includes following your healthcare provider's instructions about not putting weight on the affected leg and foot (non-weight bearing).

Keep REGRANEX Gel and all medicines out of the reach of children. Do not use REGRANEX Gel for a condition for which it was not prescribed. Do not give REGRANEX Gel to other people, even if they have the same symptoms that you have. It may harm them.

Read the Medication Guide before you start using REGRANEX Gel and each time you get a refill. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

Important Safety Information


An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of REGRANEX (becaplermin) Gel, 0.01% in a postmarketing retrospective cohort study. REGRANEX Gel should only be used when the benefits can be expected to outweigh the risks. REGRANEX Gel should be used with caution in patients with known malignancy.

Important Safety Information

People who use 3 or more tubes of REGRANEX (becaplermin) Gel may have an increased risk of death from cancer.

You should talk with your healthcare provider about the possible benefits and risks to you if you use more than 3 tubes of REGRANEX Gel. If you already have cancer, you and your healthcare provider should carefully consider whether you will use REGRANEX Gel.